198 related articles for article (PubMed ID: 29905030)
1. Decreased Expression of Serine/Arginine-Rich Splicing Factor 1 in T Cells From Patients With Active Systemic Lupus Erythematosus Accounts for Reduced Expression of RasGRP1 and DNA Methyltransferase 1.
Kono M; Kurita T; Yasuda S; Kono M; Fujieda Y; Bohgaki T; Katsuyama T; Tsokos GC; Moulton VR; Atsumi T
Arthritis Rheumatol; 2018 Dec; 70(12):2046-2056. PubMed ID: 29905030
[TBL] [Abstract][Full Text] [Related]
2. Serine Arginine-Rich Splicing Factor 1 (SRSF1) Contributes to the Transcriptional Activation of CD3ζ in Human T Cells.
Moulton VR; Gillooly AR; Perl MA; Markopoulou A; Tsokos GC
PLoS One; 2015; 10(7):e0131073. PubMed ID: 26134847
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitination regulates expression of the serine/arginine-rich splicing factor 1 (SRSF1) in normal and systemic lupus erythematosus (SLE) T cells.
Moulton VR; Gillooly AR; Tsokos GC
J Biol Chem; 2014 Feb; 289(7):4126-34. PubMed ID: 24368769
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-Induced hsa-miR-10b-5p Is Elevated in T Cells From Patients With Systemic Lupus Erythematosus and Down-Regulates Serine/Arginine-Rich Splicing Factor 1.
Ramanujan SA; Cravens EN; Krishfield SM; Kyttaris VC; Moulton VR
Arthritis Rheumatol; 2021 Nov; 73(11):2052-2058. PubMed ID: 33982889
[TBL] [Abstract][Full Text] [Related]
5. Splicing factor SRSF1 controls T cell homeostasis and its decreased levels are linked to lymphopenia in systemic lupus erythematosus.
Katsuyama T; Martin-Delgado IJ; Krishfield SM; Kyttaris VC; Moulton VR
Rheumatology (Oxford); 2020 Aug; 59(8):2146-2155. PubMed ID: 32206811
[TBL] [Abstract][Full Text] [Related]
6. Defective expression of Ras guanyl nucleotide-releasing protein 1 in a subset of patients with systemic lupus erythematosus.
Yasuda S; Stevens RL; Terada T; Takeda M; Hashimoto T; Fukae J; Horita T; Kataoka H; Atsumi T; Koike T
J Immunol; 2007 Oct; 179(7):4890-900. PubMed ID: 17878389
[TBL] [Abstract][Full Text] [Related]
7. Splicing factor SRSF1 limits IFN-γ production via RhoH and ameliorates experimental nephritis.
Katsuyama T; Li H; Krishfield SM; Kyttaris VC; Moulton VR
Rheumatology (Oxford); 2021 Jan; 60(1):420-429. PubMed ID: 32810232
[TBL] [Abstract][Full Text] [Related]
8. Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity.
Katsuyama T; Li H; Comte D; Tsokos GC; Moulton VR
J Clin Invest; 2019 Dec; 129(12):5411-5423. PubMed ID: 31487268
[TBL] [Abstract][Full Text] [Related]
9. Splicing factor SRSF1 controls distinct molecular programs in regulatory and effector T cells implicated in systemic autoimmune disease.
Cassidy MF; Herbert ZT; Moulton VR
Mol Immunol; 2022 Jan; 141():94-103. PubMed ID: 34839165
[TBL] [Abstract][Full Text] [Related]
10. Splicing factor SF2/ASF rescues IL-2 production in T cells from systemic lupus erythematosus patients by activating IL-2 transcription.
Moulton VR; Grammatikos AP; Fitzgerald LM; Tsokos GC
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1845-50. PubMed ID: 23319613
[TBL] [Abstract][Full Text] [Related]
11. Associations between aberrant DNA methylation and transcript levels of DNMT1 and MBD2 in CD4+T cells from patients with systemic lupus erythematosus.
Qin HH; Zhu XH; Liang J; Yang YS; Wang SS; Shi WM; Xu JH
Australas J Dermatol; 2013 May; 54(2):90-5. PubMed ID: 23127209
[TBL] [Abstract][Full Text] [Related]
12. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA.
Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Wong HK; Kammer GM; Tsokos GC
Arthritis Rheum; 2001 Jun; 44(6):1336-50. PubMed ID: 11407693
[TBL] [Abstract][Full Text] [Related]
13. mRNA expression analysis confirms CD44 splicing impairment in systemic lupus erythematosus patients.
Latini A; Novelli L; Ceccarelli F; Barbati C; Perricone C; De Benedittis G; Conti F; Novelli G; Ciccacci C; Borgiani P
Lupus; 2021 Jun; 30(7):1086-1093. PubMed ID: 33794704
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Characterization of
Molineros JE; Singh B; Terao C; Okada Y; Kaplan J; McDaniel B; Akizuki S; Sun C; Webb CF; Looger LL; Nath SK
Front Immunol; 2019; 10():1066. PubMed ID: 31164884
[TBL] [Abstract][Full Text] [Related]
15. AMP-activated protein kinase regulates alternative pre-mRNA splicing by phosphorylation of SRSF1.
Matsumoto E; Akiyama K; Saito T; Matsumoto Y; Kobayashi KI; Inoue J; Yamamoto Y; Suzuki T
Biochem J; 2020 Jun; 477(12):2237-2248. PubMed ID: 32453427
[TBL] [Abstract][Full Text] [Related]
16. Splicing factor SRSF1 controls autoimmune-related molecular pathways in regulatory T cells distinct from FoxP3.
Cassidy MF; Herbert ZT; Moulton VR
Mol Immunol; 2022 Dec; 152():140-152. PubMed ID: 36368121
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex.
Moulton VR; Tsokos GC
J Biol Chem; 2010 Apr; 285(17):12490-6. PubMed ID: 20118245
[TBL] [Abstract][Full Text] [Related]
18. Global DNA methylation, DNMT1, and MBD2 in patients with systemic lupus erythematosus.
Liu CC; Ou TT; Wu CC; Li RN; Lin YC; Lin CH; Tsai WC; Liu HW; Yen JH
Lupus; 2011 Feb; 20(2):131-6. PubMed ID: 21078759
[TBL] [Abstract][Full Text] [Related]
19. Analysis of associations between the patterns of global DNA hypomethylation and expression of DNA methyltransferase in patients with systemic lupus erythematosus.
Zhu X; Liang J; Li F; Yang Y; Xiang L; Xu J
Int J Dermatol; 2011 Jun; 50(6):697-704. PubMed ID: 21595664
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms/mutations of TCR-zeta-chain promoter and 3' untranslated region and selective expression of TCR zeta-chain with an alternatively spliced 3' untranslated region in patients with systemic lupus erythematosus.
Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Kammer GM; Tsokos GC
J Autoimmun; 2001 Mar; 16(2):133-42. PubMed ID: 11247639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
